Chunxu Yang

发表

ABC294640, a sphingosine kinase 2 inhibitor, enhances the antitumor effects of TRAIL in non-small cell lung cancer

C. Xie, Zhihao Wang, Shaoxing Sun, 2015, Cancer biology & therapy.

Absence of death receptor translocation into lipid rafts in acquired TRAIL-resistant NSCLC cells.

Yunfeng Zhou, Junhong Zhang, C. Xie, 2013, International journal of oncology.

Redistribution of DR4 and DR5 in lipid rafts accounts for the sensitivity to TRAIL in NSCLC cells.

Yunfeng Zhou, J. Xiong, Junhong Zhang, 2011, International journal of oncology.

Penetration Enhancing of an Erythrocyte-Mimicking Nanoplatform via Papaverine for Radiosensitization

Chunxu Yang, Jinrui Zhang, Huaicheng Wang, 2021, International journal of nanomedicine.

Concomitant overexpression of EGFR and CXCR4 is associated with worse prognosis in a new molecular subtype of non-small cell lung cancer.

Yunfeng Zhou, C. Xie, F. Zhou, 2013, Oncology reports.

A Retrospective Cohort Study Evaluates Clinical Value of Anlotinib in Persistent, Metastatic, or Recurrent Cervical Cancer After Failure of First-Line Therapy

Yunfeng Zhou, C. Xie, Shaoxing Sun, 2021, Drug design, development and therapy.

α7‑nAchR agonist GTS‑21 reduces radiation‑induced lung injury.

C. Xie, J. Chen, X. Tian, 2018, Oncology reports.

SBI0206965, a novel inhibitor of Ulk1, suppresses non-small cell lung cancer cell growth by modulating both autophagy and apoptosis pathways.

Junhong Zhang, C. Xie, Shaoxing Sun, 2017, Oncology reports.

Expression of β-catenin and OPG in human non-small cell lung cancer and their clinical significance

Sheng, Wang, C. Xie, 2016 .

β-catenin is regulated by USP9x and mediates resistance to TRAIL-induced apoptosis in breast cancer.

Junhong Zhang, C. Xie, F. Zhou, 2016, Oncology reports.

The interaction between different types of activated RAW 264.7 cells and macrophage inflammatory protein-1 alpha

Yunfeng Zhou, Yongjun Zhou, C. Xie, 2011, Radiation oncology.

Adjuvant Pelvic Radiotherapy in Ovarian Cancer: Outcomes By Risk Factors

C. Xie, Jiarui Chen, Zijie Mei, 2021 .

DDDT_A_335870 4665..4674

Yunfeng Zhou, C. Xie, Shaoxing Sun, 2021 .

MicroRNA-320 regulates the radiosensitivity of cervical cancer cells C33AR by targeting β-catenin

J. Li, Yunfeng Zhou, C. Xie, 2016, Oncology letters.

Additional chemotherapy improves survival in stage II–III pulmonary sarcomatoid carcinoma patients undergoing surgery: a propensity scoring matching analysis

C. Xie, Jiangbo Ren, Y. Gong, 2020, Annals of translational medicine.

The Ultrastructural Difference between CD133-positive U251 Glioma Stem Cells and Normal U251 Glioma Cells

You Wang, Yunfeng Zhou, C. Xie, 2012, Ultrastructural pathology.

Characteristics of homologous recombination repair pathway genes mutation in ovarian cancers

Shaoxing Sun, Zijie Mei, Z. Yi, 2022, Cancer Innovation.

Elevated expression of USP9X correlates with poor prognosis in human non-small cell lung cancer.

You Wang, Yunfeng Zhou, C. Xie, 2015, Journal of thoracic disease.

The miR-15 Family Enhances the Radiosensitivity of Breast Cancer Cells by Targeting G2 Checkpoints

C. Xie, Zijie Mei, Chunxu Yang, 2015, Radiation research.

Optimal dose limitation strategy for bone marrow sparing in intensity-modulated radiotherapy of cervical cancer

Shupeng Chen, C. Xie, D. Jiang, 2019, Radiation Oncology.

Results on efficacy and safety of cancer treatment with or without tumor necrosis factor-related apoptosis-inducing ligand-related agents: A meta-analysis.

C. Xie, Zonghuan Li, Shaoxing Sun, 2014, Molecular and clinical oncology.

Involvement of cdc25c in cell cycle alteration of a radioresistant lung cancer cell line established with fractionated ionizing radiation.

J. Li, Yunfeng Zhou, C. Xie, 2013, Asian Pacific journal of cancer prevention : APJCP.

Deubiquitinase USP9X deubiquitinates β-catenin and promotes high grade glioma cell growth

Yunfeng Zhou, C. Xie, Zhihao Wang, 2016, Oncotarget.